Vitamin B12 Market - 2024-2032
The Vitamin B12 Market was valued at US$ 350.12 million in 2024 and is anticipated to reach US$ 592.63 million by 2032, at a CAGR of 0.068 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Vitamin B12 Market.
This report delivers a comprehensive overview of the Vitamin B12 Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vitamin B12 Market. The Vitamin B12 Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2032.
Vitamin B12 Market Scope:
By Product
This report delivers a comprehensive overview of the Vitamin B12 Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vitamin B12 Market. The Vitamin B12 Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2032.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Vitamin B12 Market.
This report delivers a comprehensive overview of the Vitamin B12 Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vitamin B12 Market. The Vitamin B12 Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2032.
Vitamin B12 Market Scope:
By Product
- Cyanocobalamin
- Hydroxocobalamin
- Methyl cobalamin
- Adenosyl cobalamin
- Plant-based
- Animal-based
- Tablets
- Capsules
- Powders
- Others
- Food and Beverage
- Animal Feed
- Personal Care
- Others
- Hoffmann-La Roche Ltd.
- Bayer AG
- Merck Group
- Johnlee Pharmaceuticals Pvt. Ltd
- American Regent Inc
- Koninklijke DSM N.V.
- EUROAPI
- Pharmavit
- Supreem Pharmaceuticals Mysore Pvt. Ltd.
- Arshine Feed Additives Co., Ltd.
This report delivers a comprehensive overview of the Vitamin B12 Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vitamin B12 Market. The Vitamin B12 Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2032.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product
3.2. Snippet by Source
3.3. Snippet by Composition
3.4. Snippet by Application
3.5. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Popularity of Vegan and Vegetarian Diets
4.1.1.2. Growing Geriatric Population
4.1.2. Restraints
4.1.2.1. Potential for Adverse Effects
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Sustainability Analysis
5.6. DMI Opinion
6. BY PRODUCT
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
6.1.2. Market Attractiveness Index, By Product
6.2. Cyanocobalamin*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Hydroxocobalamin
6.4. Methyl cobalamin
6.5. Adenosyl cobalamin
7. BY SOURCE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
7.1.2. Market Attractiveness Index, By Source
7.2. Plant-based*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Animal-based
8. BY COMPOSITION
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Composition
8.1.2. Market Attractiveness Index, By Composition
8.2. Tablets*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Capsules
8.4. Powders
8.5. Others
9. BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Food and Beverage*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Animal Feed
9.4. Personal Care
9.5. Others
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Composition
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. US
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Composition
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Composition
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Composition
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. Australia
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Composition
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. COMPANY PROFILES
12.1. Hoffmann-La Roche Ltd.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Bayer AG
12.3. Merck Group
12.4. Johnlee Pharmaceuticals Pvt. Ltd
12.5. American Regent Inc
12.6. Koninklijke DSM N.V.
12.7. EUROAPI
12.8. Pharmavit
12.9. Supreem Pharmaceuticals Mysore Pvt. Ltd.
12.10. Arshine Feed Additives Co., Ltd. (*LIST NOT EXHAUSTIVE)
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product
3.2. Snippet by Source
3.3. Snippet by Composition
3.4. Snippet by Application
3.5. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Popularity of Vegan and Vegetarian Diets
4.1.1.2. Growing Geriatric Population
4.1.2. Restraints
4.1.2.1. Potential for Adverse Effects
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Sustainability Analysis
5.6. DMI Opinion
6. BY PRODUCT
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
6.1.2. Market Attractiveness Index, By Product
6.2. Cyanocobalamin*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Hydroxocobalamin
6.4. Methyl cobalamin
6.5. Adenosyl cobalamin
7. BY SOURCE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
7.1.2. Market Attractiveness Index, By Source
7.2. Plant-based*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Animal-based
8. BY COMPOSITION
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Composition
8.1.2. Market Attractiveness Index, By Composition
8.2. Tablets*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Capsules
8.4. Powders
8.5. Others
9. BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Food and Beverage*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Animal Feed
9.4. Personal Care
9.5. Others
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Composition
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. US
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Composition
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Composition
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Composition
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. Australia
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Composition
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. COMPANY PROFILES
12.1. Hoffmann-La Roche Ltd.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Bayer AG
12.3. Merck Group
12.4. Johnlee Pharmaceuticals Pvt. Ltd
12.5. American Regent Inc
12.6. Koninklijke DSM N.V.
12.7. EUROAPI
12.8. Pharmavit
12.9. Supreem Pharmaceuticals Mysore Pvt. Ltd.
12.10. Arshine Feed Additives Co., Ltd. (*LIST NOT EXHAUSTIVE)
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
